|
|
Thomson Financial Business Description:
| The Group's principal activity is to manufacture and market innovative pharmaceutical and biotechnological products. It includes research and drug manufacture for neurological disorders. The Group manufacures medicines for central nervous system disorders, allergies, respiratory diseases, cardiovascular diseases, inflammatory disorders, epilepsy, multiple sclerosis and cancer therapy. The research and development team works on antibody research. Their products include Keppra, Xyzal, Nootropi, Cimzia, Vimpat, Neupro, Tussionex and Metadate. The Group operates mainly in Europe, the United States, Asia, Africa, Oceania and Middle East. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on UCB S.A.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
